Publication | Closed Access

Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy

Combinatorial ChemistryMedicinal ChemistryNitric Oxide DonorsCox-2 InhibitorsDrug DiscoveryMedicineAnti-cancer AgentHeterocycle ChemistryDrug DevelopmentPharmacologyNovel Ferrocene-pyrazole DerivativesBiomolecular Engineering